In this edition, early lung cancer detection improves survival rates; incidental respiratory findings on low-dose CT lung cancer screening common; certain patients may derive more benefit from immunotherapy for non-small cell lung cancer and more.
Read the full coverage here:
Early lung cancer detection improves survival rates
Incidental respiratory findings on low-dose CT lung cancer screening common
Certain patients may derive more benefit from immunotherapy for non-small cell lung cancer
Bispecific antibody shows durable benefit in advanced solid tumors
Enhertu receives priority review for HER2-mutated non-small cell lung cancer
References:
Healio Interview
Pinsky PF, et al. Chest. 2022;doi:10.1016/j.chest.2021.11.015.
Patel K, et al. JNCI Cancer Spectr. 2022;doi:10.1093/jncics/pkac015
Bispecific antibody shows durable benefit in advanced solid tumors
